How to Help Your Patients Save Money on Kevzara: A Provider's Guide to Savings Programs

For rheumatologists and other prescribers, discussing medication cost is part of delivering complete care. Kevzara (sarilumab) carries a list price of approximately $4,774–$5,555 per 28-day supply—a cost that would be prohibitive for most patients without insurance and manufacturer support programs. This guide gives you a comprehensive, up-to-date reference for helping your patients access Kevzara affordably in 2026.

The Kevzara Cost Reality: What Patients Face Without Help

Understanding the baseline cost landscape helps identify which program each patient needs:

Uninsured patients: Full list price of $4,774–$5,555 per fill. Without assistance, this is financially impossible for most patients.

Commercially insured patients: Specialty tier copay typically $150–$500+ before savings programs. With KevzaraConnect: potentially $0/month.

Medicare Part D patients: Specialty tier copays of $100–$400+ depending on plan and benefit phase; manufacturer copay cards not applicable; PAP may apply for low-income patients.

Medicaid patients: Minimal cost share on plans that cover Kevzara; coverage varies significantly by state; prior authorization typically still required.

Program 1: KevzaraConnect Copay Card (Commercially Insured Patients)

The KevzaraConnect Copay Card is the highest-impact savings tool for commercially insured patients. Here's what providers need to know to enroll patients effectively:

Eligible patients: Commercially insured only (employer-sponsored, marketplace, individual plans)

Benefit: As low as $0 per month; up to $15,000 maximum annual assistance

Ineligible: Medicare, Medicaid, VA, TRICARE, DOD, any government-funded program

Enrollment: Call 1-844-538-9272 or visit kevzara.com/starting-kevzara/kevzaraconnect-copay-card

Process: Provider or patient completes enrollment form with current Kevzara prescription attached; copay card is activated for use at specialty pharmacy

Note: Some insurance plans use copay accumulator or maximizer programs that prevent manufacturer assistance from counting toward the patient's deductible. If a patient on the copay card is still reporting high out-of-pocket costs, investigate whether their plan uses such a program and contact KevzaraConnect for guidance.

Program 2: KevzaraConnect Patient Assistance Program (Uninsured/Underinsured)

For patients who are uninsured or functionally underinsured (including some Medicare patients who cannot afford their required cost share), Sanofi's PAP through KevzaraConnect provides Kevzara at no cost. Key program details:

Patient must be a US resident with a valid Kevzara prescription for an FDA-approved indication

Must be uninsured, underinsured, or meet specific Medicare/Medicaid criteria

Income eligibility criteria based on household income and family size

Enrollment through KevzaraConnect: 1-844-538-9272; provider signature required on application

Program 3: Free 30-Day Bridge Trial Supply

For newly starting patients, while prior authorization is being processed, KevzaraConnect offers a one-time 30-day free trial supply through TheraCom specialty pharmacy. To activate for your patient:

Download the KevzaraConnect Voucher Form from kevzara.com/hcp

Complete patient information and sign the voucher

Fax completed voucher + a 30-day Kevzara prescription to TheraCom: Fax to the number on the voucher form (345 International Blvd, Ste 200, Brooks, KY 40109)

Patient will receive a call from TheraCom within 2 business days to arrange delivery

Medicare Patients: Options Beyond the Copay Card

Medicare patients need different strategies since manufacturer copay cards are off-limits. For Medicare patients on Kevzara, here's your toolkit:

KevzaraConnect PAP: Low-income Medicare patients who meet income criteria may receive Kevzara through the PAP at no cost

Extra Help / Low Income Subsidy (LIS): Federal program reducing Part D costs for eligible beneficiaries; refer patients to SSA.gov or SHIP counselors for application assistance

Medicare Prescription Payment Plan: Allows patients to spread annual Part D out-of-pocket costs over monthly installments rather than paying large amounts at the start of the year

Plan switching at open enrollment: Assist patients in comparing Part D and Medicare Advantage plans to find those with lower specialty tier cost-sharing for Kevzara

PA Denials and Step Therapy: Cost Reduction Through Access Wins

Sometimes the most effective cost reduction strategy is overturning a formulary barrier. When Kevzara is denied for step therapy or as a non-preferred specialty drug:

Submit a detailed letter of medical necessity explaining why Kevzara is specifically required (e.g., clinical trial evidence supporting its use in PMR where it is the only approved biologic; patient contraindication to tocilizumab; prior failed response to preferred biologic)

Request expedited review ("urgent PA") for patients with active disease affecting quality of life or function

Use KevzaraConnect's PA navigation support for appeal assistance—their case managers know the payer landscape and can guide the documentation process

Helping Patients Find Kevzara: medfinder as a Provider Resource

For patients who have coverage and prior authorization but are still struggling to locate a specialty pharmacy that can fill their prescription on time, medfinder.com/providers is a resource you can recommend. medfinder calls specialty pharmacies on patients' behalf to identify which ones can fill Kevzara. This is particularly useful when a patient's primary specialty pharmacy has a backlog or when the patient needs to quickly identify an in-network alternative.

Provider Savings Quick Reference: Kevzara

Commercially insured: KevzaraConnect Copay Card → $0/month, up to $15,000/yr (1-844-538-9272)

Uninsured / underinsured: KevzaraConnect PAP → Free medication (income-based criteria)

New patients awaiting PA: KevzaraConnect Free Trial → 30-day supply via TheraCom

Medicare, low-income: Extra Help (SSA.gov), KevzaraConnect PAP, Medicare Prescription Payment Plan

PA denied / step therapy: Medical necessity letter + KevzaraConnect PA navigation support